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a b s t r a c t
Slowly progressive neuromuscular diseases include but are not limited to: facioscapulo-
humeral muscular dystrophy (FSHD) and limb-girdle muscular dystrophy (LGMD), heredi-
tary motor and sensory neuropathy (HMSN) and spinal muscular atrophy type III (SMA3).
The purpose of this study is to present an evaluation of basic and complex activities of daily
living in patients suffering from these diseases.
The study was conducted on a group of 58 Polish patients: 25 patients with HMSN, 19 with
LGMD and FSHD and 14 with SMA3. The research instrument consisted of two parts: a
specially designed questionnaire and Nottingham Extended ADL Index. The survey was
voluntary, anonymous and self-administered.
In our study the highest scores on the NEADL scale were achieved by HMSN patients, and
the lowest by patients with SMA3. The research revealed statistically signiﬁcant differences
between all the groups in the total number of points achieved on NEADL scale.
The study revealed that for most respondents the most difﬁcult tasks were those in the
area of 'mobility'. It is consistent with reports in the literature, which conﬁrm that out of the
slowly progressive neuromuscular diseases included in this research, SMA3 is a disease
leading to the biggest limitations in performing the activities of everyday life.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
Available online at www.sciencedirect.com
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Most neuromuscular diseases have a progressive character
and lead to different degrees of impairment in physical* Corresponding author at: Faculty of Rehabilitation, Józef Piłsudski Univ
Warsaw, Poland.
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0028-3843/© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Nperformance. Among them we can distinguish a group of
slowly progressive neuromuscular diseases which are charac-
terized by usually milder course and therefore allow the
patients to maintain independence for a longer time.
These include disease entities such as: facioscapulohumeralersity of Physical Education in Warsaw, ul. Marymoncka 34, 00-968
eurological Society.
Table 1 – Characteristics of somatic parameters of the studied groups.
Group N Age [years] Height [cm] Weight [kg] BMI
HMSN 25 39.28  11.35 171.4  9.64 70.50  18.12 23.87  5.21
FSHD/LGMD 19 36.21  13.21 168.9  12.35 64.74  15.80 22.36  4.41
SMA 3 14 36.64  10.72 163.3  7.83 60.64  17.03 22.63  5.94
Table 2 – Nottingham Extended Activities of Daily Living
Index.
Mobility questions – Do you:
Walk around outside?
Climb stairs?
Get in and out of the car?
Walk over uneven ground?
Cross roads?
Travel on public transport?
In the kitchen – Do you:
Manage to feed yourself?
Manage to make yourself a hot drink?
Take hot drinks from one room to another?
Do the washing up?
Make yourself a hot snack?
Domestic tasks – Do you:
Manage your own money when you are out?
Wash small items of clothing?
Do your own shopping?
Do a full clothes wash?
Leisure activities - Do you:
Read newspapers or books?
Use the telephone?
Write letters?
Go out socially?
Manage your own garden?
Drive a car?
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phy (LGMD), hereditary motor sensory neuropathy (HMSN)
and spinal muscular atrophy type III (SMA3) [1–5].
These diseases display common symptoms during their
course, such as: muscle weakness, fatigue, problems with
walking and with performing activities of daily living [6]. For
most patients maintaining independence in the basic activi-
ties of daily living (ADL), such as moving around or self-
feeding, reﬂects the desire to remain autonomous. There are a
lot of scales used to evaluate ADL [7]. Numerous studies in
patients with neuromuscular diseases evaluated ADL on
Barthel scale (Barthel Index-BI) [1,8–11]. However, it was noted
that Barthel scale may not be adequate to evaluate ADL in
patients with slowly progressive neuromuscular diseases. It is
too general and might not be accurate enough for the
assessment of patients with milder forms of neuromuscular
diseases [1,8]. Moreover, there is often a need to supplement
the evaluation of basic ADL with the assessment of complex
activities of daily living. For this purpose instrumental scales
were created, also called Extended Activities of Daily Living
(EADL) scales. These scales, used in the evaluation a patient's
condition, are a link between functional scales and scales used
for the measurement of quality of life [7,12].
Stubgen observes that it seems improper to believe that the
scales should be speciﬁc for a particular disease entity.
Probably more important is to use scales and tests that will
be targeted to the nature of the problems that occur in patients
[11]. Nottingham Extended ADL Index (NEADL) is a scale which
was created and validated for the assessment of people with
stroke [7]. It evaluates both basic and complex activities of
daily living and can be an alternative for the evaluation of
patients with slowly progressive neuromuscular diseases.
Supplemented with a specially designed questionnaire it
seems to be a good instrument for evaluation of this group of
patients.
The purpose of this study is to present an evaluation of
basic and complex activities of daily living in patients with
slowly progressive neuromuscular disease.
2. Material and methods
The research was based on an anonymous self-administered
online survey in which patients participated voluntarily. It
consisted of two parts. The ﬁrst was a specially designed
questionnaire containing 35 closed questions. The second part
was based on the Nottingham Extended ADL Index (NEADL).
The study was conducted in Polish patients with neuro-
muscular diseases. Survey questionnaires were distributed to
people with neuromuscular diseases in electronic form and 96
completed questionnaires were sent back. The patients were
divided into three main groups according to the type ofdisease. Finally 58 questionnaires were chosen for the analysis
– 25 from patients with HMSN, 19 from patients with LGMD and
FSHD and 14 from patients with SMA3.
Table 1 presents the characteristics of the groups in terms
of age, height, body weight and BMI.
NEADL scale evaluates independence in four areas of
everyday life: mobility, kitchen, domestic activities, and leisure
activities. In these areas there are 6, 5, 4, and 6 points
respectively. In total, the scale consists of 21 questions [13].
Full NEADL scale is presented in Table 2.
The authors have modiﬁed the scoring scale. Each point is
reported on 1–4 score scale, where 1 means I don't do it at all, 2 – I
do it with help, 3 – I do it on my own with difﬁculty, 4 – I do it on my
own easily. The full scale value ranges from 21 to 84 points.
2.1. Statistical methods
The statistical analysis was performed using computer
program Statistica (v. 12). Mean values and standard devia-
tions of somatic data were calculated and the percent
difference comparison was applied. For quantitative variables
arithmetic mean and standard deviations (SD) were calculat-
ed. Shapiro-Wolf normality test was used to check whether the
distribution of the surveyed characteristics is consistent with
normal distribution. Analysis of variance (ANOVA) and post
Fig. 1 – Interaction plot for the question 'Do you walk over
uneven ground?' in the three groups. Group 1 – HMSN,
Group 2 – FSHD/LGMD, Group 3 – SMA3.
Table 3 – The detailed results obtained on NEADL scale.
NEADL Max points CMT FSHD/LGMD SMA 3 p values Effect size
d-Cohen
Mobility 24 20.88  2.5 14.79  5.6 9.79  3.8 1 vs 2 0.00000
1 vs 3 0.00000
2 vs 3 0.0009
1 vs. 2 1.403
1 vs 3 3.414
2 vs 3 1.047
Kitchen 20 19.24  1.2 15.84  4.7 13.07  5.3 1 vs. 2 0.005
1 vs 3 0.00001
2 vs 3 0.04
1 vs. 2 0.985
1 vs 3 1.589
2 vs 3 0.548
Home 16 14.52  2.6 11.68  3.9 9.79  2.8 1 vs. 2 0.004
1 vs 3 0.00003
2 vs 3 0.09
1 vs. 2 0.86
1 vs 3 1.744
2 vs 3 0.555
Leisure Activities 24 19.28  3.7 17.58  3.9 16.43  2.6 1 vs. 2 0.12
1 vs 3 0.01
2 vs 3 0.3
1 vs 2 0.447
1 vs 3 0.89
2 vs 3 0.345
Total on NEADL scale 84 73.92  8.74 59.89  13.98 49.07  11.93 1 vs. 2 0.0001
1 vs 3 0.00000
2 vs 3 0.009
1 vs. 2 1.203
1 vs 3 2.376
2 vs 3 0.832
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 2 2 2 – 2 2 7224hoc Tukey's honest signiﬁcant difference test (HSD) were used
to check the signiﬁcance of the differences in the results.
Effect size (ES) was also measured to conﬁrm the size of
the statistically signiﬁcant difference. The standard level of
statistical signiﬁcance p < 0.05 was adopted.
3. Results
72% of the patients with HMSN are professionally active, 12%
declared that they received a disability pension due to illness,
and 16% declared that they were not professionally active. In
the group of FSHD and LGMD patients 37% are professionally
active, 53% receive a disability pension, and 11% are
professionally inactive. Half of the SMA3 patients claimed
they received a disability pension due to illness, 43% said they
were professionally active and the remaining 7% stated that
they were inactive.
When asked about medical aids, some patients with SMA3
and dystrophy declared they used of a wheelchair – 71% and
21% respectively. In HMSN group 12% of patients used one
crutch, and as many as 68% declared they needed an
orthopedic appliance for their lower limb.
On NEADL scale the highest score was obtained by patients
with HMSN – 73.92  8.74, the lowest by people with SMA3 –
49.07  11.93. Statistically signiﬁcant differences ( p < 0.05)
were noted between the total scores obtained on NEADL scale
by all the groups. Under the assumption of the effect size scale
developed by Cohen [14] (Cohen, 1988), the difference between
all the groups is large (ES > 0.8). The biggest difference is
between HMSN group and SMA3 (ES-2, 376). The detailed
results obtained on NEADL scale can be found in Table 3.
We can observe similar distribution of the subscores on
NEADL scale for mobility and kitchen – in both areas the highest
score was obtained by people with HMSN and it was 20.88  2.5
and 19.24  1.2 respectively. The lowest score was obtained by
SMA3 patients who received 9.79  3.8 for mobility and 13.07
 5.3 for kitchen. Statistically signiﬁcant differences were
found between all groups. ES among all groups is big
(ES > 0.8), the biggest between patients with HMSN and
SMA3 (ES-3, 414).In the area of mobility patients with HMSN as well as those
with muscular dystrophies received the lowest number of
points for the question 'Do you walk over uneven ground?' and it
was 3.12  0.78 and 2.16  1.17 respectively (Fig. 1). Statistically
signiﬁcant differences were found between the two groups. ES
between the patients with HMSN and those with muscular
dystrophies was 0.43, which means it is interpreted as average.
SMA3 patients got the lowest score for the question 'Do you
climb stairs?' – 1.29  0.61 points - and statistically signiﬁcant
differences were found between all groups (Fig. 2). The biggest
difference was between HMSN and SMA3 groups (ES-0.88). In
one of the closed questions of the survey 79% patients with
SMA3 declared that climbing and descending the stairs was
impossible for them. The same answer was given by 26% of
patients with muscular dystrophies.
In kitchen area for all patients the easiest activity was
'managing to feed myself'. The lowest score for this activity was
obtained by patients with dystrophies, who received 3.58
 0.69 for this question and statistically signiﬁcant difference
was found between this group and the group with HMSN. ES
was 0.4 and is interpreted as average.
Fig. 2 – Interaction plot for the question 'Do you climb
stairs?' in three groups. Group 1 – HMSN, Group 2 – FSHD/
LGMD, Group 3 – SMA3.
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replied that it is not sufﬁcient. Such answer was given by 100%
of patients with SMA3, 84% patients with muscular dystro-
phies and 72% with neuropathy.
4. Discussion
The purpose of this study is to present an evaluation of basic
and complex activities of daily living in patients with slowly
progressive neuromuscular diseases.
When reviewing literature, the authors found no study in
which EADL in patients with neuromuscular diseases was
evaluated using Nottingham Extended ADL Index (NEADL). It
was also revealed that EADL measurement is usually only one
of many endpoints, following the evaluation of muscle
strength or functional tests [1,4,8,9,11,15].
Functional assessment of patients focused on performing
activities of daily living is especially important because the
loss of function does not always go together with progressive
weakening of muscle strength. Dunaway et al. describe a case
of a patient with SMA3, where they demonstrate that it is a
slowly progressive disease with a progressive loss of function
with no measurable decrease in muscle strength [5]. Iannac-
cone et al. observed and assessed 73 children and adults with
SMA type 2 and 3 over the period from 2 to 6 years. They noted
that 10 of them experienced a loss of functional ability with the
absence of deterioration of muscle strength. This means
that the loss of function has to be the result of other factors,
or that the functional assessment is more sensitive than
the measurement of muscle strength for detecting small
changes [5,16].
In the present study, the highest score on NEADL scale was
obtained by patients with HMSN. Hereditary motor and
sensory neuropathy, of which the most common form is
Charcot–Marie–Tooth disease type 1A (CMT1A), is a chronic,
mild and slowly progressive polyneuropathy, which is
characterized by symmetric weakness and wasting of distal
muscles, mainly in the lower limbs [17].Our results are consistent with the research carried out by
Menotti et al., in which patients with CMT1A eligible to take
part in the assessment obtained 96.3  3.8 points out of 100 on
Barthel scale. In this study the authors observed smaller
number and lower intensity in performing some ADL in
patients with CMT1A compared to healthy individuals. It was
noticed that they climbed fewer stairs – the differences were
visible when climbing up and when descending the stairs.
Moreover, patients with CMT1A reported fewer position
changes – moving from sitting to standing position and the
other way round. The authors speculate that people with
neuropathy avoid the most demanding tasks, which require a
lot of muscle work, both concentric and eccentric, in the lower
limbs [10]. This is consistent with our results, where 48% of
patients with HMSN conﬁrmed that they have a problem with
standing up from a squatting position and must support
themselves against the items located near them. When asked
about the stairs, 36% declared that both climbing and
descending the stairs is difﬁcult for them.
In the area of mobility, the most difﬁcult task for people with
HMSN was 'walking over uneven ground'. Perhaps it derives
from the fact that one of the characteristic symptoms of
hereditary motor and sensory neuropathy, in addition to
weakening of distal muscles in the lower limbs, is propriocep-
tive dysfunction, which is noticeable even at the beginning
stage of the disease [17]. Proprioceptors are one of sensory
receptors which are involved in the control of balance and
their dysfunction can lead to an impaired postural control [18].
It may be reﬂected in the problems patients experience with
reduced mobility on uneven surfaces. In the future it would be
useful to extend the study by adding a questionnaire on risk of
falls in these patients.
Also for patients with muscular dystrophies the hardest
thing to do in the area of mobility was 'walking over uneven
ground', but in comparison to HMSN group they obtained much
lower score and the difference was statistically signiﬁcant.
Such difference is also noticeable in the question about
performing a squat, where 37% patients with muscular
dystrophies declared that a squat was impossible for them
to perform, while in HMSN group it was not possible for only
4% of respondents. Similarly, climbing and descending stairs
were perceived as impossible by 26% of patients with
dystrophies.
FSHD is characterized by a speciﬁc distribution pattern of
muscle weakness beginning from facial muscles, muscles
which stabilize the scapula and arm muscles. Then weakening
may involve peroneal muscles and pelvic girdle muscles. Quite
often abdominal muscles can also be weakened [19]. LGMD is
typically characterized by a progressive weakness of pelvic
girdle and shoulder girdle muscles as well as proximal limb
muscles [1,20].
In a study conducted by Lue et al. FSHD patients obtained
97.8  4.7 out of 100 points on Barthel scale, while those with
LGMD got only 85.6  20.2 points. The difference between
these patients was also detected on Vignos scale which
evaluates functional activity of the lower limbs. 50% of
patients with FSHD were on grade 1 of Vignos scale, which
means that 'they walk and climb stairs without assistance', but the
percentage of patients with LGMD on this grade was much
lower – only 14.8%. Much more often people with a limb-girdle
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could 'walk and climb stairs slowly with aid of railing', and as
many as 18.5% were on grade 9, which means moving around
in a wheelchair. For comparison the lowest result for FSHD
patients was grade 5 and it actually referred to only one person
[9]. In another study carried out by Lue et al., 80% of patients
with FSHD were classiﬁed on Barthel scale as 'completely
independent' and 15% as 'partially independent' and the hardest
thing for them was climbing and descending stairs [8]. And
according to a study of Kilmer et al., 48% of people with FSHD
were able to climb and descend stairs without assistance, 38%
were placed on grades 2–3 of Vignos scale, but as many as 14%
used a wheelchair [21].
For patients with muscular dystrophies as well as for those
with HMSN the easiest thing to do in the area of mobility was
'getting in and out of the car'. This is not surprising in the case of
people with neuropathy, because weakness of the muscles
located above the knee joints, which are heavily engaged in
this activity, may not occur until the later stage of the disease
[22]. Patients with muscular dystrophies also declared that it
was the easiest activity in the mobility area, but their score was
lower than the score obtained by HMSN patients and the
difference was statistically signiﬁcant. This is probably related
to the fact that proximal muscles of the lower limbs and pelvic
girdle muscles are affected at an early stage of this disease. The
manner in which this activity was performed should also been
taken into account. They might have, for example, supported
themselves against the elements of the car.
The lowest result on NEADL scale was obtained by patients
with SMA3, and the biggest difference was observed between
them and the people with HMSN (EF-2, 376).
In a study conducted by Chung et al. SMA classiﬁcation was
adopted from Zerres and the patients with SMA3 were divided
into two types. Type IIIa for those who got sick before the age of
3, and type IIIb when they got sick between the age of 3 and 30.
The authors used on WeeFIM scale to evaluate the perfor-
mance. Patients with SMAIIIa obtained 16.7  5.6 out of
35 points in the area of mobility and people with SMAIIIb
got 18.2  12.1. The conclusion of the authors was that in
performing most activities in the area of mobility patients with
SMA needed help [4].
In our study people with SMA3 in the area of mobility
obtained 9.79  3.8 points out of 24. For them the most difﬁcult
activity in this area was 'climbing stairs', which is consistent
with the results of the study carried out by Chung et al., where
it was also observed that the biggest obstacle for the autonomy
of the patients was struggling with the stairs [4] (Chung).
Statistically patients with SMA3 begin to walk on their own
at the age of 15 months and lose this ability at the age of 12
years. Patients for whom the biggest achievement was walking
with assistance, usually lose this ability at the age of 7 [5].
Dunaway et al. presented the results of a ﬁve-year observation
of a patient with SMA3. Just as it is described in the literature,
the patient lost his motor functions over the course of time,
however he was able to move with assistance for about 2 years
longer than expected – until he was 9 years old [5]. In our study
71% of patients with SMA3 declared that they used a
wheelchair. Russman et al. reported that in the moment
SMA patients are no longer able to walk, they also lose the
ability of raising their arms above the head [23]. When weasked a question: 'is raising your arms above the head difﬁcult?'
71% of patients with SMA3 gave afﬁrmative answer.
For all patients the easiest activity in the 'kitchen' area was
'managing to feed myself'. The lowest score for this activity was
obtained by patients with dystrophies. Perhaps this derives
from the fact that in this group some of the patients suffer
from FSHD and one of the ﬁrst symptoms of this particular
disease is weakness of the facial muscles, which can lead to
difﬁculty in eating.
This study was conducted in patients with different slowly
progressive neuromuscular diseases. Although each of these
disease entities has a different genetic background and a
different clinical course, they have several common char-
acteristics. These include muscle atrophy, paresis and reduced
muscle tension. Each disease has a distinct distribution
pattern of muscle weakness and the order in which individual
muscle groups are affected.
For most patients who took part in the survey the most
difﬁcult tasks were those in the area of mobility. The scores
obtained here were for most patients much lower than the
scores in other areas. What is interesting to note is that
patients suffering from different diseases reported the same
limitations in activities of daily living. This similarity is
particularly reﬂected in the responses given by patients with
HMSN and muscular dystrophies, for whom the easiest and
the most difﬁcult tasks in the area of mobility were the same. Of
course patients with muscular dystrophies obtained a signiﬁ-
cantly lower score for these tasks, but the limited activity
remained the same. The primary goal of physiotherapy is to
adjust therapeutic procedures to the problems reported by
patients, therefore an assessment of the limitations that
patients experience in social life and in performing everyday
activities is a valuable supplement to physiotherapeutical
examination.
It seems that it might be particularly interesting to conduct
a re-examination of these patients in order to evaluate and
compare the progress of each disease.
Our study is consistent with reports in the literature, which
conclude that out of the slowly progressive neuromuscular
diseases included in this research, SMA3 is a disease leading to
the biggest limitations in performing activities of everyday life.
So far, the only available treatment for most patients with
neuromuscular diseases is physiotherapy. When asked: 'Do
you think that access to rehabilitation is sufﬁcient?' all patients with
SMA3 gave negative response. The same answer was given by
84% of people with muscular dystrophies and 72% of patients
with hereditary neuropathy. It is disturbing because physio-
therapy is one of the basic pillars of medical care for people
with neuromuscular diseases. Because of the chronic and
progressive nature of these diseases patients should have
access to systematic and repetitive rehabilitation. In the
process of rehabilitation should be engaged a dedicated team,
where, apart from a physiotherapist, the patient would have
access to such specialists as an occupational therapist, a
psychologist and a speech therapist.
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